Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6FZ4

Structure of GluK1 ligand-binding domain in complex with N-(7-fluoro-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl)-2-hydroxybenzamide at 1.85 A resolution

6FZ4 の概要
エントリーDOI10.2210/pdb6fz4/pdb
分子名称Glutamate receptor ionotropic, kainate 1,Glutamate receptor ionotropic, kainate 1, GLYCEROL, SULFATE ION, ... (6 entities in total)
機能のキーワードkainate receptor ligand-binding domain, gluk1-s1s2, membrane protein
由来する生物種Rattus norvegicus (Rat)
詳細
タンパク質・核酸の鎖数1
化学式量合計30083.69
構造登録者
Kastrup, J.S.,Frydenvang, K.,Mollerud, S. (登録日: 2018-03-14, 公開日: 2019-01-23, 最終更新日: 2024-01-17)
主引用文献Pallesen, J.,Mollerud, S.,Frydenvang, K.,Pickering, D.S.,Bornholdt, J.,Nielsen, B.,Pasini, D.,Han, L.,Marconi, L.,Kastrup, J.S.,Johansen, T.N.
N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
Acs Chem Neurosci, 10:1841-1853, 2019
Cited by
PubMed Abstract: Among the ionotropic glutamate receptors, the physiological role of kainate receptors is less well understood. Although ligands with selectivity toward the kainate receptor subtype GluK1 are available, tool compounds with selectivity at the remaining kainate receptor subtypes are sparse. Here, we have synthesized a series of quinoxaline-2,3-diones with substitutions in the N1-, 6-, and 7-position to investigate the structure-activity relationship (SAR) at GluK1-3 and GluK5. Pharmacological characterization at native and recombinant kainate and AMPA receptors revealed that compound 37 had a GluK3-binding affinity ( K) of 0.142 μM and 8-fold preference for GluK3 over GluK1. Despite lower binding affinity of 22 at GluK3 ( K = 2.91 μM), its preference for GluK3 over GluK1 and GluK2 was >30-fold. Compound 37 was crystallized with the GluK1 ligand-binding domain to understand the SAR. The X-ray structure showed that 37 stabilized the protein in an open conformation, consistent with an antagonist binding mode.
PubMed: 30620174
DOI: 10.1021/acschemneuro.8b00726
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.85 Å)
構造検証レポート
Validation report summary of 6fz4
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon